AQIX Trademark

Trademark Overview


On Friday, May 3, 2013, a trademark application was filed for AQIX with the United States Patent and Trademark Office. The USPTO has given the AQIX trademark a serial number of 79134000. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, March 6, 2026. This trademark is owned by Aqix Limited. The AQIX trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

[Laboratory services for analytical testing; laboratory services relating to the researching of pharmaceuticals and solutions for medical and surgical use and solutions for supporting human and animal cells, tissue and organs, solutions for use and application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation, solutions for storing human and animal organs, tissues and cells, solutions for replacing, synthesizing, diluting, rehydrating and expanding human and animal blood, intravascular and extravascular fluids, solutions for testing drugs on human and animal cells, tissue and organs, media for stem cell and DNA research and therapy; scientific research; medical transplant research services; medical research; scientific analysis of human tissue and human serum for medical research; stem cell and DNA scientific and medical research services; chemical research and development services; chemical, medical and scientific testing and a...

Solutions for medical and clinical use in supporting human and animal cells, tissue and organs; solutions for medical and clinical use and application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation, such preservation being to preserve stem cells and their therapeutic applications; solutions for intravenous use for medical, surgical and veterinary purposes; cultures for growing cells, bacteria [ and viruses ] for medical and clinical purposes; solutions for medical and clinical use for replacing, synthesizing, diluting, rehydrating and expanding human and animal blood, intravascular and extravascular fluids; solutions for medical and clinical use for cell, organ and tissue preservation and the creation of a homeostasis to regulate the environment of cells, organs and tissues; solutions for medical and clinical use for testing drugs on ex vivo perfused human and animal cells, tissue and organs; cell, bacteria and virus growth m...

Chemicals for use in scientific analysis; chemicals for scientific purposes, namely, making pharmaceutical and veterinary preparations, being media for storing organs, tissue and cells; cell, bacteria and virus growth media for use with cell, bacterial and viral cultures in scientific research
aqix

General Information


Serial Number79134000
Word MarkAQIX
Filing DateFriday, May 3, 2013
Status709 - CANCELLED - SECTION 71
Status DateFriday, March 6, 2026
Registration Number4473215
Registration DateTuesday, January 28, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2013

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Certificate of Correction for RegistrationIn the statement, Page 1, line 16, "and viruses" should be deleted. In the statement, Page 2, line 1, after "aforesaid" "being or" should be inserted. In the statement, Page 2, lines 1-2, after "pharmaceuticals" "substances, preparations, compositions or solutions" should be inserted. In the statement, Page 2, line 2, after "aforesaid" "being" should be inserted. In the statement, Page 2, line 3, before "treatment" "detection or" should be inserted. In the statement, Page 2, line 3, after "diseases" ", or for use with tissue or organs infected by herpes or related viral diseases" should be inserted.
Certificate of Correction for RegistrationThe following "none of the aforesaid relating to ready-made pharmaceuticals and none of the aforesaid for use in connection with the treatment of herpes and related viral diseases" should be inserted at end of the class 5.
Goods and Services[Laboratory services for analytical testing; laboratory services relating to the researching of pharmaceuticals and solutions for medical and surgical use and solutions for supporting human and animal cells, tissue and organs, solutions for use and application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation, solutions for storing human and animal organs, tissues and cells, solutions for replacing, synthesizing, diluting, rehydrating and expanding human and animal blood, intravascular and extravascular fluids, solutions for testing drugs on human and animal cells, tissue and organs, media for stem cell and DNA research and therapy; scientific research; medical transplant research services; medical research; scientific analysis of human tissue and human serum for medical research; stem cell and DNA scientific and medical research services; chemical research and development services; chemical, medical and scientific testing and analysis for medical research purposes; testing of pharmaceutical solutions for medical research purposes; quality control services for others; clinical medical and scientific research; conducting of clinical trials for others; design and development of new technology and products for other uses in medical and veterinary fields;] Information, advisory and consultancy services relating to [ all of the aforesaid] * laboratory services for analytical testing and to scientific research *
Goods and ServicesSolutions for medical and clinical use in supporting human and animal cells, tissue and organs; solutions for medical and clinical use and application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation, such preservation being to preserve stem cells and their therapeutic applications; solutions for intravenous use for medical, surgical and veterinary purposes; cultures for growing cells, bacteria [ and viruses ] for medical and clinical purposes; solutions for medical and clinical use for replacing, synthesizing, diluting, rehydrating and expanding human and animal blood, intravascular and extravascular fluids; solutions for medical and clinical use for cell, organ and tissue preservation and the creation of a homeostasis to regulate the environment of cells, organs and tissues; solutions for medical and clinical use for testing drugs on ex vivo perfused human and animal cells, tissue and organs; cell, bacteria and virus growth media, storage media and transportation media for medical or clinical use for stem cell and DNA research and therapy; pharmaceutical transfer agents or components for pharmaceuticals in the form of solutions for medical use for application in infusion therapy, organ transplant perfusion and cell or tissue bio-specimen collection and preservation; tissue regenerative pharmaceutical preparations and solutions; stem cells for medical and veterinary purposes; clinical diagnostic preparations for medical or veterinary use; clinical medical reagents; medical diagnostic reagents for proteomic, genomic and metabolomic analysis of tissues, cells, bacteria and viruses and testing the stability of homeostasis within organs, tissues, cells, bacteria and viruses for medical use; * none of the aforesaid * being or * relating to ready-made pharmaceuticals * substances, preparations, compositions or solutions * and none of the aforesaid * being * for use in connection with the * detection or * treatment of herpes and related viral diseases *, or for use with tissue or organs infected by herpes or related viral diseases *
Goods and ServicesChemicals for use in scientific analysis; chemicals for scientific purposes, namely, making pharmaceutical and veterinary preparations, being media for storing organs, tissue and cells; cell, bacteria and virus growth media for use with cell, bacterial and viral cultures in scientific research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 6, 2026
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeA - Sec. 7(d) - Class(es) in a Multiple Class Registration
Class Status DateThursday, February 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 6, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAqix Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAqix Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAqix Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, August 8, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 13, 2013APPLICATION FILING RECEIPT MAILED
Thursday, August 22, 2013ASSIGNED TO EXAMINER
Saturday, August 24, 2013NON-FINAL ACTION WRITTEN
Sunday, August 25, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 27, 2013REFUSAL PROCESSED BY MPU
Tuesday, August 27, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 17, 2013REFUSAL PROCESSED BY IB
Tuesday, September 24, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 24, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 7, 2013ASSIGNED TO LIE
Tuesday, October 8, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2013PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 13, 2013NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 28, 2014REGISTERED-PRINCIPAL REGISTER
Monday, April 28, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 17, 2014FINAL DISPOSITION PROCESSED
Tuesday, June 17, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 4, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 14, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 1, 2015LIMITATION OF GOODS RECEIVED FROM IB
Thursday, May 7, 2015LIMITATION FROM THE IB EXAMINED AND ENTERED
Thursday, May 7, 2015ASSIGNED TO PARALEGAL
Thursday, May 7, 2015CORRECTION UNDER SECTION 7 - PROCESSED
Thursday, January 7, 2016PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, March 12, 2016INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, October 27, 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 16, 2017LIMITATION OF GOODS RECEIVED FROM IB
Thursday, August 10, 2017LIMITATION FROM THE IB EXAMINED AND ENTERED
Thursday, August 10, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 10, 2017CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, April 10, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 13, 2018INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Monday, January 28, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, July 28, 2020TEAS SECTION 7 REQUEST RECEIVED
Tuesday, July 28, 2020TEAS SECTION 71 & 15 RECEIVED
Wednesday, November 25, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 18, 2020NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 4, 2021CANCELLED SEC. 7 - PARTIAL
Thursday, February 4, 2021REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, February 4, 2021NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Friday, February 5, 2021NOTICE OF PARTIAL CANCELLATION SEC. 7 SURRENDER EMAILED
Saturday, January 28, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, October 12, 2023INTERNATIONAL REGISTRATION RENEWED
Friday, March 6, 2026CANCELLED SECTION 71